An efficient and facile synthesis of D-cycloserine has been developed from D-serine with 61% overall yield employing protectiondeprotection strategy. Different parameters affecting the impurities content and yield of D-cycloserine have been studied. Mild reaction conditions provided the product with remarkable purity (>99%) and high stability.
Similar content being viewed by others
References
Global Tuberculosis Report 2014; World Health Organization, 2015. ISBN 978 92 4 156480 9.
Suthar, A. B.; Lawn, S. D.; Amo, J. D.; Getahun, H.; Dye, C.; Sculier, D.; Sterling, T. R.; Chaisson, R. E.; Williams, B. G.; Harries, A. D.; Granich, R. M. PLoS Med. 2012, 9, e1001270. DOI https://doi.org/10.1371/journal.pmed.1001270.
(a) Addressing the Threat of Drug-Resistant Tuberculosis: A Realistic Assessment of the Challenge: Workshop Summary; Giffin, R.; Robinson, S., Eds.; National Academies Press: Washington, 2009. (b) Rendon, A.; Tiberi, S.; Scardigli, A.; D'Ambrosio, L.; Centis, R.; Caminero, J. A.; Migliori, G. B. J. Thorac. Dis. 2016, 8, 2666.
Keshavjee, S. Background on the Green Light Committee and the Second Line Tuberculosis Drug Supply Chain; National Academies Press: Washington, 2012.
Kurosawa, H. J. Antibiot., Ser. B 1952, 5, 682.
(a) Stammer, C. H.; Wilson, A. N.; Holly, F. W.; Folkers, K. J. Am. Chem. Soc. 1955, 77, 2346. (b) El-Obeid, H. A.; Al-Badr, A. A. Analytical Profile of D-cycloserine in Analytical Profiles of Drug Substances; Academic Press: New York, 1989, Vol. 18, p. 567. (c) Hardman, J. G. Goodman and Gilman's. The Pharmacological Basis of Therapeutics; McGraw-Hill: New York, 1995, 9th ed., p. 1164. (d) Kuehl, F. A., Jr.; Wolf, F. J.; Trenner, N. R.; Peck, R. L.; Buhs, R. P.; Howe, E.; Putter, I.; Hunnewell, B. D.; Ormond, R.; Downing, G.; Lyons, J. E.; Newstead, E.; Chaiet, L. Folkers, K. J. Am. Chem. Soc. 1955, 77, 2344.
(a) Hall, R. G.; Leff, R. D.; Gumbo, T. Pharmacotherapy 2009, 29, 1468. (b) Keshavjee, S.; Farmer, P. E. N. Engl. J. Med. 2012, 367, 931.
(a) Schade, S.; Paulus, W. Int. J. Neuropsychopharmacol. 2016, 19, 102. (b) Myers, K. M.; Carlezon, W. A., Jr. Biol. Psychiatry 2012, 71, 947.
Hoffman, S. G. Depression Anxiety 2014, 31, 175.
Connors, K. A.; Amidon, G. L.; Stella, V. J. Chemical Stability of Pharmaceuticals: A Handbook for Pharmacists; John Wiley & Sons: New York, 1986, 2nd ed., p. 394.
Kartseva, V. D.; Bruns, B. P.; Kruzhkova, N. G.; Bannova, N. A. Pharm. Chem. J. 1972, 6, 615.
(a) Kim, H. K.; Park, K. J. J. Tetrahedron Lett. 2012, 53, 4090. (b) Plattner, P. A.; Boller, A.; Frick, H.; Furst, A.; Hegedus, B.; Kirchensteiner, H.; Majnoni, St.; Schlapfer, R.; Spiegelberg, H. Helv. Chim. Acta 1957, 40, 1531. (c) Ruuo, Z.; Weitan, L.; Binjie, G. CN Patent 105646385, 2016.
Kim, H. K.; Park, K. J. Tetrahedron Lett. 2012, 53, 1668.
El-Obeid, H. A.; Al-Badr, A. A. Analytical Profiles of Drug Substances; Elsevier, 1990, vol. 18, p. 567.
Li, X.; Meng, X.; Duan, H.; Wang, L.; Wang, S.; Zhang, Y.; Qin, D. Arch. Pharm. Pharm. Med. Chem. 2010, 8, 473.
Isidro-Llobet, A.; Alvarez, M.; Albericio, F. Chem. Rev. 2009, 109, 2455.
(a) Awasthi, A. K.; Kumar, B.; Aga, M. A.; Basha, S. T.; Reddy, C. S.; Kumar, P. ChemistrySelect 2017, 2, 9722. (b) Awasthi, A. K.; Kumar, L.; Tripathi, P.; Golla, M.; Aga, M. A.; Reddy, C. S.; Kumar, P. ACS Omega 2017, 2, 5460. (c) Kumar, B.; Aga, M. A.; Rouf, A.; Shah, B. A.; Taneja, S. C. RSC Adv. 2014, 4, 17206. (d) Aga, M. A.; Kumar, B.; Rouf, A.; Shah, B. A.; Andotra, S. S.; Taneja, S. C. Helv. Chem. Acta 2013, 96, 969.
Greene, T. W.; Wuts, P. G. M. Protective Groups in Organic Synthesis; John Wiley & Sons: New York, 2007, 4th еd.
Reddy, S.; Kumar, S.; Reddy, G. R. Tetrahedron Lett. 2000, 41, 6285.
Stammer, C. H.; Kartha, C. C.; Chaturvedi, N. C.; McKinney, J. D. J. Med. Chem. 1970, 13, 1013.
Riva, E.; Gagliardi, S.; Mazzoni, C.; Passarella, D.; Rencurosi, A.; Vigo, D.; Martinelli, M. J. Org. Chem. 2009, 74, 3540.
Giacomelli, G.; Porcheddu, A.; Salaris, M. Org. Lett. 2003, 5, 2715.
(a) Floyd, C. D.; Lewis, C. N.; Patel, S. R.; Whittaker, M. Tetrahedron Lett. 1996, 37, 8045. (b) Richter, L. S.; Desai, M. C. Tetrahedron Lett. 1997, 38, 321. (c) Chen, J. J.; Spatola, A. F. Tetrahedron Lett. 1997, 38, 1511. (d) Mellor, S. L.; McGuire, C.; Chan, W. C. Tetrahedron Lett. 1997, 38, 3311. (e) Bauer, U.; Ho, W.; Koskinen, A. M. P. Tetrahedron Lett. 1997, 38, 7233. (f) Ngu, K.; Patel, D. V. J. J. Org. Chem. 1997, 62, 7088. (g) Robinson, D. E.; Holladay, M. W. Org. Lett. 2000, 2, 2777. (h) Zhang, W.; Zhang, L.; Li, X.; Weigel, J. A.; Hall, S. E.; Mayer, J. P. J. Comb. Chem. 2001, 3, 151.
United States Pharmacopoeia; 2000, 25th ed., p. 2049.
Ahuja, S.; Alsante K. M. Handbook of Isolation and Characterization of Impurities in Pharmaceuticals; Academic Press, 2003, p. 6.
Kasture, A. V.; Wadodkar, S. G.; Mahadik, K. R.; More, H. V. Pharmaceutical Analysis; Pune: Nirali Prakashan, 1997, Vol. 1, p. 12.
Baer, E. J. Biol. Chem. 1955, 212, 25.
Stammer, C. H. J. Org. Chem. 1962, 27, 2957.
Ongania, K. H. Arch. Pharm (Weinheim, Ger.) 1979, 312, 958.
Hidy, P. H. J. Am. Chem. Soc. 1955, 77, 2345.
The authors acknowledge management of Micro Labs Ltd., Active Pharmaceutical Ingredients Research and Development Centre for providing research and analytical facilities.
Author information
Authors and Affiliations
Corresponding author
Additional information
A Supplementary information file containing 1H and 13C NMR spectra and HPLC analysis of the synthesized compounds is available at the journal website at http://link.springer.com/journal/10593.
Published in Khimiya Geterotsiklicheskikh Soedinenii, 2017, 53(11), 1248–1253
Electronic supplementary material
ESM 1
(PDF 2390 kb)
Rights and permissions
About this article
Cite this article
Awasthi, A.K., Kumar, B., Aga, M.A. et al. An efficient and facile synthesis of D-cycloserine substantially free from potential impurities. Chem Heterocycl Comp 53, 1248–1253 (2017). https://doi.org/10.1007/s10593-018-2197-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10593-018-2197-y